http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114304287-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f95abca1950057c5f979b0ce5c0d1e89 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23D9-00 |
| filingDate | 2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada6a78481039402a1e62024c72ed599 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b7f8449c43c5c9b2d988114fc66be2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c1b5e3069a6f6d98a8ed727d3ecd9cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0feab8009963130bb2a764a811cb4e9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e12dae362a61b32c5de723955c519e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_352e5181c15ea84ba72efbbb09f65e8f |
| publicationDate | 2022-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114304287-A |
| titleOfInvention | Fat component used in sarcopenia syndrome medical formula food, preparation method and application |
| abstract | The invention discloses a fat component used in a sarcopenia syndrome medical formula food, a preparation method and an application thereof, and belongs to the field of formula food for special medical purposes. The fat component is calculated in mass percentage: medium chain triglyceride: 30% to 60%; nutritional oil: supplemented to 100%; the nutritional oil is composed of two of sesame oil, linseed oil, krill oil, fish oil, and peanut oil. One or more kinds of oil mixture. In the fatty acid composition of the present invention, the level of ω-3 polyunsaturated fatty acids is high, and there are two combinations of phospholipid type and glyceride type. During digestion and absorption, ω-3 polyunsaturated fatty acids can be gradually utilized, which has anti-inflammatory effect and can also Activating the mTOR signaling pathway and AMPK signaling pathway, promoting protein synthesis, inhibiting the relative expression of NF-κB, inhibiting inflammatory responses, increasing the proportion and fluidity of polyunsaturated fatty acids in the cell membrane, and contributing to sarcopenia syndrome. |
| priorityDate | 2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.